Skip to main content
Caplight Logo









Avitia

Avitia

Private
MontrealHealthcare & Life Scienceshttps://www.avitia.bio/

Last Round

Seed

Feb 27, 2025

Total Funding Raised

$5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Avitia is a healthtech company that provides an AI-powered molecular testing platform designed to accelerate cancer diagnostics and targeted treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticsnext-generation sequencingNGSliquid biopsyprecision medicinebioinformaticscancer diagnosticsgenomic data analyticsclinical decision supportmedical AILIMS integrationAI-driven diagnosticsdigital pathologydecentralized testinglab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avitia Comparables

Compare Avitia with similar companies based on industry and business-model similarity.

Avitia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GeneSilico
82%
Hedera Dx
80%
SeqOne
77%

Avitia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 27, 2025

Key People

Founding team and executive leadership

James Lumsdaine

Chief Executive Officer

Executive Team

Avitia Investors

Notable investors and investment history

Avitia investors
InvestorRounds
PacBridge Capital PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 2945% MoM, from 83 to 2.5K.

  • Oct 2, 2025

    Partnered with Genoscience to expand cancer testing access to 50+ locations.

Avitia Filings

Explore SEC and related filing metadata, where available.

Avitia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avitia's valuation, stock price, and market status.

Is Avitia a public or private company?

Avitia is a private company.

What is the current stock price of Avitia?

Avitia is a private company with no public stock price. No recent secondary market data is available.

How much is Avitia worth (valuation)?

Valuation information for Avitia is not publicly available.

Can I buy Avitia stock?

Avitia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avitia's last funding round?

Avitia's most recent funding round was Seed on February 27, 2025.

Who are the main investors in Avitia?

Key investors in Avitia include PacBridge Capital Partners.

Will Avitia IPO soon?

No public IPO plans have been announced for Avitia.

How can I track Avitia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avitia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range13
Year Founded2025
Last FundingFeb 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?